Almirall to market Merck Sharp diabetes drug (Reuters, 4 November 2008)

17 Nov 2008


The pharmaceutical company Almirall (Spain) has reached an agreement with Merck Sharp & Dohme to market its Tesavel Type 2 diabetes drug in Spain.

Full article


Share this story